** Shares of drugmaker Cumberland Pharmaceuticals CPIX.O rise ~108% to $2.57 premarket
** CPIX said on Monday the U.S. FDA approved co's supplemental new drug application to treat paracetamol overdose
** Paracetamol, chemically known as acetaminophen, is the leading cause of acute liver failure in the U.S. - CPIX
** The drug, branded as Acetadote, simplifies dosing and reduces risk of medication errors while staying effective - co
** As of last close, stock had fallen 30.7% YTD
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.